Laura V. T.
- Country
- Spain
- Department
- Medical oncology
Research Overview
- Efficacy and Safety of Zolbetuximab with Nab-Paclitaxel and Gemcitabine in Claudin 18.2 Positive Metastatic Pancreatic Adenocarcinoma
- Phase 1b/3 Evaluation of Bemarituzumab, Chemotherapy, and Nivolumab in FGFR2b-Overexpressing Advanced Gastric and Gastroesophageal Junction Cancer
- Efficacy of Zolbetuximab Plus mFOLFOX6 Versus Placebo Plus mFOLFOX6 in Claudin 18.2-Positive, HER2-Negative Metastatic Gastric or GEJ Adenocarcinoma
Data & Insights
Has run more than one trial at 124 of 285 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating advanced gastric and gastroesophageal junction (GEJ) cancers, with particular focus on targeted therapeutic approaches for these conditions.
- HER2-positive gastric cancer management
- Advanced gastroesophageal adenocarcinoma treatment
- Metastatic GEJ cancer interventions
Their expertise extends to novel therapeutic combinations involving targeted antibodies and immunotherapy approaches.
Molecular Targeted Therapies
The investigator focuses on innovative treatments targeting specific molecular markers, including CLDN18.2 expression and HER2 status in gastrointestinal cancers.
- Monoclonal antibody therapeutics
- Combination therapy strategies
- Biomarker-driven treatment approaches
Their work encompasses the evaluation of novel therapeutic agents in combination with established treatment protocols.
Pancreatic Cancer Research
The investigator conducts studies in metastatic pancreatic adenocarcinoma, exploring innovative treatment combinations and targeted therapeutic approaches.
- First-line treatment strategies
- Novel drug combinations
- Targeted therapy assessment
Their research includes evaluation of survival outcomes in advanced pancreatic cancer patients using targeted therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.